Nearly doubled in two months and now back up to listing price with 20,000 clients, cash, growth and prestigious awards......hmmmmm. Cheap? You betcha.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025